WebAn example of nonbiodegradable drug-eluting devices is the Relieva Stratus™ MicroFlow Spacer (Acclarent, Menlo Park, CA, USA), originally approved by the FDA for saline delivery [199]. WebThe Relieva Stratus™ MicroFlow Spacer (Relieva Stratus) is a drug-eluting stent that is temporarily implanted into the ethmoid sinus. The reservoir of the stent is filled with …

Ethmoidal drug‐eluting stent therapy is not superior to nasal ...

WebOct 7, 2024 · Of those, 41 frontal sinuses were treated with balloon sinuplasty alone and 35 frontal sinuses with both sinuplasty (Acclarent device) and a non-absorbable stent (Relieva Stratus™ MicroFlow spacer). WebTrade Name: Relieva Stratus MicroFlow Spacer Common Name: Frontal Sinus Spacer Indications For Use: The MicroFlow Spacer (Frontal) is indicated for use as a postoperative spacer to maintain an opening to the frontal sinuses within the first 14 days following surgery. The MicroFlow Spacer also helps to prevent obstruction. toad frog rods

The MicroFlow Spacer: A Drug-Eluting Stent for the Ethmoid Sinus

WebDec 19, 2024 · The AcclarentRelieva Stratus MicroFlow Spacer designed with a microporous reservoir for drug release is approved in the United States for use with saline. Recently, … WebNov 20, 2008 · Acclarent (Menlo Park, CA), the company that originally introduced balloon sinuplasty, has developed the Relieva Stratus MicroFlow Spacer, a new device described by the company as “a temporary implant delivered directly to the ethmoid complex [with] a reservoir with hundreds of precision-formed micropores …[for] targeted, local bathing of ... WebJul 1, 2011 · An example of nonbiodegradable drug-eluting devices is the Relieva Stratus™ MicroFlow Spacer (Acclarent, Menlo Park, CA, USA), originally approved by the FDA for … pennington beach lymington